Labiotech.eu

Best in Biotech 21 Sep 2023

Recent advancements in prostate cancer research over the past year

Prostate cancer is the second most commonly occurring cancer in men. More than 1.4 million people were diagnosed with prostate cancer in 2020, according to the World Cancer Research Fund International. While some prostate cancers develop too slowly, to the extent that some people will not need any treatment during their lifetime, some grow very […]

September 21, 2023 - 10 minutesmins - By Roohi Mariam Peter

Opinion 20 Sep 2023

The next frontier in genomic technologies for rare diseases

By Neil Ward, VP and General Manager at PacBio EMEA It’s been 40 years since the passage of the Orphan Drug Act, which catalyzed the development of hundreds of therapies for rare diseases, with more than half approved in the last decade. More recently in 2022, the U.K. government launched a Rare Diseases Action Plan […]

September 20, 2023 - 7 minutesmins - By External Contributor

Best in Biotech 19 Sep 2023

Five biotech companies taking Los Angeles by storm

Known throughout history for being home to the iconic scene of Hollywood, in recent years Los Angeles has also become a thriving biotech hub, after years of playing second fiddle in the U.S. to the likes of South San Francisco and Boston. In this article, we take a look at five of the best Los […]

September 19, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 18 Sep 2023

Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities

The U.K. is rejoining the European Union’s (EU’s) $100 billion research program Horizon Europe, after being locked out of the deal amid post Brexit tensions for more than two years. This comes after months of negotiations between the U.K. government and the EU, in an attempt to broaden opportunities for researchers in the U.K.. British […]

September 18, 2023 - 5 minutesmins - By Roohi Mariam Peter

Podcast 15 Sep 2023

Beyond Biotech podcast 63 – Fighting cancer with STRIs

This week’s podcast is sponsored by Vetter. On this week’s episode, we have a conversation with Steve Worland, CEO of eFFECTOR Therapeutics. eFFECTOR is a clinical-stage biopharmaceutical company pioneering the development of a new class of cancer drugs referred to as STRIs (selective translation regulation inhibitors). eFFECTOR’s STRI product candidates target the eIF4F complex and […]

September 15, 2023

Best in Biotech 15 Sep 2023

Five latest advancements in NASH research

Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD) – a condition where fat builds up in the liver, potentially causing liver damage or cirrhosis. Despite the severity of the disease, and the fact that approximately 25% of U.S. adults have NAFLD, while 5% have NASH, there is yet to be […]

September 15, 2023 - 8 minutesmins - By Willow Shah-Neville

In Depth 14 Sep 2023

Righting wrongs: genetic justice for Henrietta Lacks

For what would have been Henrietta Lacks’ 103rd birthday last month, her family, who settled a lawsuit with Thermo Fisher – a multinational biotech company that had used her cells without seeking consent for several years – regarded the win as a “fitting day” for justice. While the settlement took place behind closed doors, where Henrietta […]

September 14, 2023 - 7 minutesmins - By Roohi Mariam Peter

Startup Scout 13 Sep 2023

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

A healthy immune system is supposed to defend the body against disease and infection, but in autoimmune diseases, the immune system malfunctions, and instead attacks the body’s healthy cells, tissues, and organs. Despite recent progress in therapeutic options for autoimmune disorders, a significant unmet need remains, which is why Mysthera Therapeutics is aiming to take […]

September 13, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 11 Sep 2023

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

With biotech funding trends always evolving, HSBC Innovation Banking’s inaugural Venture Healthcare Report lays out the trends seen in the first half (1H) of 2023, where valuations underwent a necessary reset, and venture capitalists emerged from their cautious stance, eventually embarking on a fresh wave of investments. However, an overall decline in investment was still […]

September 11, 2023 - 5 minutesmins - By Willow Shah-Neville

Podcast 8 Sep 2023

Beyond Biotech podcast 62 – cytokine-based drugs

As September 8 is Stand Up To Cancer Day, one area of promising research lies in cytokine-based drugs, which have the potential to activate T cells against tumors. Historically, toxicity from systemic cytokine treatment has remained a challenge, prompting several companies to explore ways to “engineer” drugs with modified cytokine molecules like interleukin 2 (IL-2) […]

September 8, 2023

In Depth 8 Sep 2023

The rise of lab-grown dairy: a sustainable solution for the future

Recently, there has been a lot of talk surrounding cultivated meat, especially after Upside Foods and Good Meat received final U.S. Department of Agriculture (USDA) approval to sell lab-grown meat for the first time in the U.S.. And, although perhaps less talked about, cultivated – or lab-grown – dairy could also be set to take […]

September 8, 2023 - 8 minutesmins - By Willow Shah-Neville

Startup Scout 6 Sep 2023

Meet the startup developing novel cancer therapies from snake venom crotoxin

Snake venom is probably not the first thing that springs to mind when thinking about treatments or therapies, but the potential biotechnological and biomedical applications of animal venom components are actually widely recognized in scientific research. Now, Dublin-based startup Celtic Biotech is harnessing the potential of snake venom in an attempt to come up with […]

September 6, 2023 - 7 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Recent advancements in prostate cancer research over the past year

The next frontier in genomic technologies for rare diseases

Five biotech companies taking Los Angeles by storm

Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities

Beyond Biotech podcast 63 – Fighting cancer with STRIs

Five latest advancements in NASH research

Righting wrongs: genetic justice for Henrietta Lacks

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

Beyond Biotech podcast 62 – cytokine-based drugs

The rise of lab-grown dairy: a sustainable solution for the future

Meet the startup developing novel cancer therapies from snake venom crotoxin

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!